But taking the drug off the market, he said, was the right thing, too.
``We did the right things based on what we knew at the time,'' he said.
Despite the criticism directed at his agency, Galson remains unapologetic.
The next day surprised FDA officials learned the drug would be pulled.
The FDA's opportunity to act independently on Vioxx ended on Sept. 27, when the fax came from Merck asking for an urgent meeting with senior officials.
